TrialThe Pediatric infectious disease journal2020

Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial.

Susanna Esposito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.